A Study Evaluating a New Radiation Treatment Workflow (NGDS)
NCT07824583 is an interventional trial sponsored by Varian, a Siemens Healthineers Company. As of 21 Nov 2026, it is recruiting participants. It studies Abdominal Cancer, Liver Cancer, Adult and 3 more conditions. The registry lists an enrollment of 20 participants at 2 sites in 1 country. The registry lists a start date of 31 Jul 2026 and a primary completion date of 28 Feb 2027. One of its registered investigators has a FindMyKOL profile.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT07824583 |
| Status | Recruiting |
| Study type | Interventional trial |
| Lead sponsor | Varian, a Siemens Healthineers Company |
| Enrollment | 20 |
| Registered sites | 2 |
| Countries | 1 |
| Conditions | Abdominal Cancer, Liver Cancer, Adult, Lung Cancer (Diagnosis), Pancreatic Cancer and Thoracic Cancers |
| Start | 31 Jul 2026 |
| Primary completion | 28 Feb 2027 |
| Study completion | 31 May 2027 |
| Last update posted | 17 Sept 2026 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Siteman Cancer Center Washington University
St Louis
Pamela SamsonRecruiting
- University Hospital Cleveland Medical Center
Cleveland
Lauren HenkeRecruiting
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT07824583
Each answer restates registry values shown on this page.
What is NCT07824583?
NCT07824583 is an interventional trial sponsored by Varian, a Siemens Healthineers Company. It studies Abdominal Cancer, Liver Cancer, Adult and 3 more conditions.
Is NCT07824583 recruiting?
As of 21 Nov 2026, it is recruiting participants. 2 of its 2 sites list their own status as recruiting.
Where does NCT07824583 run?
The registry lists 2 sites in 1 country. Every site with a stated country is in one country: United States.
When is NCT07824583 expected to complete?
The registry lists a primary completion date of 28 Feb 2027 and a study completion date of 31 May 2027. The sponsor last updated the record on 17 Sept 2026.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.